BioSpecifics Technologies Corp. (BioSpecifics) is a biopharmaceutical company. -- BioSpecifics Technologies Corporation (Nasdaq: BSTC) has been upgraded by TheStreet Ratings from sell to hold. BioSpecifics Technologies Corp. Delaware Corporate Center II. It sells its … BIOSPECIFICS TECHNOLOGIES CORP. 2019 OMNIBUS INCENTIVE COMPENSATION PLAN (Full title of the plan) Dr. Ronald Law Principal Executive Officer 35 Wilbur Street Lynbrook, New York 11563 (Name and address of agent for service) (516) 593-7000 (Telephone number, including area code, of agent for service) Collagenase injection - BioSpecifics Technologies Corporation Alternative Names: AA-4500; AK-160; CCH; Clostridial collagenase; Collagenase clostridium histolyticum; Cordase; EN-3835; PF-5076985; Plaquase; XIAFLEX; Xiapex Latest Information Update: 28 Jan 2020 Biospecifics Technologies Corp. (NASDAQ:BSTC) Biospecifics Technologies Corp. (NASDAQ:BSTC) is a microcap stock that exchanges on the NASDAQ. About BioSpecifics Technologies Corp. BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for thirteen clinical indications to date. BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. BioSpecifics corporate headquarters are currently located at Delaware Corporate Center II, 2 Righter Parkway, Suite 200, Wilmington, DE 19803. back to top What is BioSpecifics’ fiscal year? Biospecifics Technologies Corp Buy. The analysts of H.C. Wainwright & Co. have rated Biospecifics Technologies with a Buy rating.

The organization is in the biopharmaceutical segment and as of now gets revenue from its item known as XIAFLEX in the United States, Canada and Australia, and under the name of XIAPEX in Europe. The price target was set to $ 100.00. 2 Righter Parkway, Suite 200. BioSpecifics Technologies Corp. has a 1-year low of $42.00 and a 1-year high of $69.51. BioSpecifics Technologies Corp. United States 10,369,110 March 14, 2034 Treatment Method and Product for Uterine Fibroids Using Purified Collagenase BioSpecifics Technologies Corporation … The organization is in the biopharmaceutical segment and as of now gets revenue from its item known as XIAFLEX in the United States, Canada and Australia, and under the name of XIAPEX in Europe. Wilmington, DE 19803 BioSpecifics Technologies (NASDAQ:BSTC) last issued its earnings results on Monday, May 11th.

The Company is engaged in the development of an injectable collagenase clostridium histolyticum (CCH) for … Biospecifics Technologies Corp. (NASDAQ:BSTC) Biospecifics Technologies Corp. (NASDAQ:BSTC) is a microcap stock that exchanges on the NASDAQ.